Inventor · disambiguated record
Christopher Reading
Also filed as: READING CHRISTOPHER · READING CHRISTOPHER L
21 granted patents·30 pending applications·2,114 citations·filing 1976–2025
97Inventor score
Top patents by PatentIndex Score
51 records- 0199US4474893ARecombinant monoclonal antibodiesUNIV TEXAS·Filed 1981·Granted Oct 2, 1984·1k cites·50 claims
- 0298US4714681AQuadroma cells and trioma cells and methods for the production of sameREAGENTS THE UNIVERSITY OF TEX·Filed 1984·Granted Dec 22, 1987·518 cites·56 claims
- 0395US4427690AEsters of clavulanic acidBEECHAM GROUP LTD·Filed 1976·Granted Jan 24, 1984·47 cites·211 claims
- 0494US4525352AAntibioticsBEECHAM GROUP PLC·Filed 1981·Granted Jun 25, 1985·38 cites·65 claims
- 0592US7547687B2Therapeutic treatment methodsHOLLIS EDEN PHARMACEUTICALS·Filed 2007·Granted Jun 16, 2009·45 cites·19 claims
- 0691US4110165AProcess for the production of clavulanic acidBEECHAM GROUP LTD·Filed 1976·Granted Aug 29, 1978·69 cites·19 claims
- 0789US7723532B2Pharmaceutical compositions 3HARBOR BIOSCIENCES INC·Filed 2006·Granted May 25, 2010·6 cites·15 claims
- 0889US4920061ABiological magnetic colloidsUNIV TEXAS·Filed 1986·Granted Apr 24, 1990·102 cites·15 claims
- 0989US4560552AAntibioticsBEECHAM GROUP PLC·Filed 1981·Granted Dec 24, 1985·25 cites·7 claims
- 1085US4556559AAntibioticsBEECHAM GROUP PLC·Filed 1978·Granted Dec 3, 1985·14 cites·78 claims
- 1181US8354396B2Drug identification and treatment methodHARBOR THERAPEUTICS INC·Filed 2007·Granted Jan 15, 2013·6 cites·10 claims
- 1281US4529720AAntibiotic from Streptomyces clavulicerusBEECHAM GROUP PLC·Filed 1981·Granted Jul 16, 1985·23 cites·15 claims
- 1378US4526783AAntibiotic from S. clavuligerusBEECHAM GROUP PLC·Filed 1981·Granted Jul 2, 1985·11 cites·55 claims
- 1476US6031093ASolid salts of clavulanic acidSMITHKLINE BEECHAM PLC·Filed 1995·Granted Feb 29, 2000·34 cites·1 claims
- 1575US8217025B2Drug screening and treatment methodsFLORES-RIVEROS JAIME·Filed 2007·Granted Jul 10, 2012·5 cites·14 claims
- 1675US6051703APurified clavulanic acid and salts thereofSMITHKLINE BEECHAM PLC·Filed 1995·Granted Apr 18, 2000·31 cites·7 claims
- 1775US6048977AClavulanic acid and salts thereofSMITHKLINE BEECHAM PLC·Filed 1995·Granted Apr 11, 2000·33 cites·2 claims
- 1871US4927502AMethods and apparatus using galvanic immunoelectrodesUNIV TEXAS·Filed 1989·Granted May 22, 1990·38 cites·22 claims
- 1971US2009215737A1Pharmaceutical Compositions - 2AHLEM CLARENCE NATHANIEL·Filed 2006·Application pending·0 cites
- 2068US4525353AAntibioticsBEECHAM GROUP PLC·Filed 1982·Granted Jun 25, 1985·13 cites·55 claims
- 2168US2005256095A1Asthma and colitis treatment methodsAHLEM CLARENCE N·Filed 2004·Application pending·0 cites
- 2268US2005282732A1Pharmaceutical compositions and treatment methods-7AHLEM CLARENCE N·Filed 2004·Application pending·0 cites
- 2368US2005159366A1Pharmaceutical compositions and treatment methods - 8Filed 2004·Application pending·0 cites
- 2467US8486926B2Steroid tetrol solid state formsFRINCKE JAMES·Filed 2008·Granted Jul 16, 2013·1 cites·11 claims
- 2567US6218380B1Pharmaceutical compositionsSMITHKLINE BEECHAM PLC·Filed 1991·Granted Apr 17, 2001·31 cites·13 claims
- 2666US2025340941A1Assay and methods for drug discoveryBIOVIE INC·Filed 2025·Application pending·0 cites
- 2765US2007275936A1Formulations and Treatment MethodsAHLEM CLARENCE N·Filed 2006·Application pending·0 cites
- 2864US2004220114A1Pharmaceutical compositions and treatment methodsFiled 2003·Application pending·0 cites
- 2963US2008045490A1Pharmaceutical CompositionsFRINCKE JAMES M·Filed 2006·Application pending·0 cites
- 3063US2024108636A1Compositions for treatment of neurodegenerative conditionsBIOVIE INC·Filed 2023·Application pending·0 cites
- 3163US2006088473A1Treatment screening methodsDOWDING CHARLES·Filed 2005·Application pending·0 cites
- 3261US2004116359A1Pharmaceutical compositions and treatment methodsFiled 2002·Application pending·0 cites
- 3359US2004220161A1Pharmaceutical compositions and treatment methods-6Filed 2003·Application pending·0 cites
- 3458US2005101581A1Therapeutic treatment methods 2Filed 2003·Application pending·0 cites
- 3558US2005075321A1Neurological disorder treatment methodsFiled 2004·Application pending·0 cites
- 3656US2006073099A1Treatment screening methodsFRINCKE JAMES M·Filed 2005·Application pending·0 cites
- 3754US2007129282A1Pharmaceutical treatments and compositionsAHLEM CLARENCE N·Filed 2004·Application pending·0 cites
- 3853US2006079492A1Compositions and treatment methodsAHLEM CLARENCE N·Filed 2005·Application pending·0 cites
- 3952US2008221074A1Drug Screen and Treatment MethodFLORES-RIVEROS JAIME·Filed 2007·Application pending·0 cites
- 4051US2010075937A1Patient populations and treatment methodsHOLLIS EDEN PHARMACEUTICALS·Filed 2009·Application pending·0 cites
- 4149US2014010806A1Treatment of Ocular DiseasesFRINCKE JAMES M·Filed 2013·Application pending·0 cites
- 4248US2004138187A1Therapeutic treatment methodsFiled 2003·Application pending·0 cites
- 4348US2025262223A1Methods for the treatment of biological agingBIOVIE INC·Filed 2025·Application pending·0 cites
- 4446US2003060425A1Immune modulation method using steroid compoundsFiled 2001·Application pending·0 cites
- 4546US2008153792A1Drug Identification and Treatment MethodFRINCKE JAMES M·Filed 2007·Application pending·0 cites
- 4645US2008015174A1Metabolic Disease TreatmentsREADING CHRISTOPHER L·Filed 2007·Application pending·0 cites
- 4745US2025186458A1Methods for the treatment of mild cognitive impairmentBIOVIE INC·Filed 2025·Application pending·0 cites
- 4841US2003083231A1Blood cell deficiency treatment methodFiled 2002·Application pending·0 cites
- 4938US2007014719A1Steroid analogs and characterization and treatment methodsREADING CHRISTOPHER L·Filed 2005·Application pending·0 cites
- 5035US2010227841A1Patient populations and treatment methodsHARBOR BIOSCIENCS INC·Filed 2010·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Christopher Reading files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →